Seoul, South Korea

Hongnam Sim


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hongnam Sim in Anticancer Research

Introduction

Hongnam Sim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research through his innovative work on peptides with anticancer activity. His research aims to develop effective treatments for cancer, showcasing his commitment to advancing medical science.

Latest Patents

Hongnam Sim holds 1 patent related to his groundbreaking work. The patent is titled "Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient." This invention focuses on a specific peptide that binds to the transcription factor CP2c, demonstrating prophylactic and therapeutic activities against cancer. The patent outlines the potential applications of this peptide in various compositions aimed at preventing and treating cancer.

Career Highlights

Hongnam Sim is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His role in this institution allows him to collaborate with other researchers and contribute to the academic community. His work is characterized by a strong focus on practical applications of his research, particularly in the development of health-related products.

Collaborations

Hongnam Sim has worked alongside notable colleagues, including Chul Geun Kim and Chan Gil Kim. Their collaborative efforts have furthered the research and development of innovative solutions in the field of cancer treatment.

Conclusion

Hongnam Sim's contributions to anticancer research through his patented peptide highlight the importance of innovation in medical science. His work not only advances our understanding of cancer treatment but also paves the way for future developments in health-related applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…